KVUE changes
Pick any two versions below to diff them.
- Recent events
- Nov added: 4, 2026: Kimberly-Clark completed its exchange offers for the $7.0 billion of Kenvue senior notes. Holders exchanged about $6.38 billion of Kenvue notes for new Kimberly-Clark notes and cash, and Kimberly-Clark canceled them. About $0.62 billion of Kenvue notes stay outstanding. These notes lost most of their restrictive covenants and the SEC reporting covenant. Nov 2, 2026: Kimberly-Clark completed its purchase of Kenvue. Each Kenvue share became 0.14625 Kimberly-Clark shares and $3.50 in cash. The NYSE stopped trading in Kenvue shares before the market opened on November 2, 2026, and filed to delist them. The delisting takes effect 10 days after that filing. Kenvue ended its $4.0 billion credit facility, which had no borrowings, and Kenvue LLC, now a subsidiary of Kimberly-Clark, took on the obligations of Kenvue's senior notes. Oct 30, 2026: Kenvue reported Q3 2026 results. Net sales rose 3.2%, and organic sales rose 2.9%, with volume up 1.6%. This was the fourth quarter of growth in a row. Diluted EPS was $0.22, and adjusted EPS was $0.29, up 4%. The adjusted operating margin rose to 21.9% from 21.5%, helped by productivity savings and US tariff refunds. Kenvue gave no guidance because of the pending Kimberly-Clark deal. Oct 13, 2026: The European Commission cleared Kimberly-Clark's purchase of Kenvue on the condition that Kimberly-Clark sells its feminine care business in the European Economic Area, including Kotex, Lidie, Camelia and Record, to Dilek Gida Uretim of Turkey. On the same day, Kimberly-Clark said that Kenvue noteholders gave enough consents to amend the Kenvue indenture in its exchange offer, which expires on October 27, 2026. Oct 9, 2026: Kenvue signed a supplemental indenture that removes most covenants of its senior notes. The changes take effect when Kimberly-Clark's exchange offer for the notes settles, at about the closing of the acquisition. Aug 6, 2026: Kenvue reported Q2 2026 results. Net sales rose 3.0%, and organic sales rose 1.6%, the third quarter of growth in a row. Diluted EPS was $0.24, and adjusted EPS was $0.31, up 7%. The adjusted operating margin fell to 22.1% from 22.7% because of inflation, tariffs and higher brand support. Kenvue gave no guidance because of the pending deal, and it said that it works to close the deal in the fourth quarter of 2026. May 12, 2026: CFO Amit Banati left the company, as announced in February 2026. Chief Accounting Officer Heather Howlett became interim CFO. May 7, 2026: Kenvue reported Q1 2026 results. Net sales rose 4.5%, and organic sales rose 0.7%. Diluted EPS was $0.25, up 47%, and adjusted EPS was $0.32, up 33%.